Skip to Main Content

Author Details

Sharon D Yeatts
Medical University of South Carolina
2007
95
31
PMIDPaper TitleJournal TitlePublished Year
36862515COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response.JCI Insight2023
37668620Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial.JAMA2023
37599009Selection of a statistical analysis method for the Glasgow Outcome Scale-Extended endpoint for estimating the probability of favorable outcome in future severe TBI clinical trials.Stat Med2023
37082956Early Signs of Elevated Intracranial Pressure on Computed Tomography Correlate With Measured Intracranial Pressure in the Intensive Care Unit and Six-Month Outcome After Moderate to Severe Traumatic Brain Injury.J Neurotrauma2023
37078281Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience.Stroke2023
37009524Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studies.Res Methods Med Health Sci2023
34789008Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial.Stroke2022
35381966Prolonged Automated Robotic TCD Monitoring in Acute Severe TBI: Study Design and Rationale.Neurocrit Care2022
35786002An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism.Clin Trials2022
35487617White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment.Stroke Vasc Neurol2022
35012328National Institutes of Health Stroke Scale as an Outcome in Stroke Research: Value of ANCOVA Over Analyzing Change From Baseline.Stroke2022
35306827Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial.Stroke2022
35273066Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST-3): a multicentre, randomised, blinded-endpoint, comparative effectiveness study of brain tissue oxygen and intracranial pressure monitoring versus intracranial pressure alone.BMJ Open2022
35265851The Experiences and Needs of Families of Comatose Patients After Cardiac Arrest and Severe Neurotrauma: The Perspectives of National Key Stakeholders During a National Institutes of Health-Funded Workshop.Crit Care Explor2022
33319651Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.J Neurotrauma2021
33823461White Matter Hyperintensity and Cardiovascular Disease Outcomes in the SPRINT MIND Trial.J Stroke Cerebrovasc Dis2021
34407339Early Convalescent Plasma for High-Risk Outpatients with Covid-19.N Engl J Med2021
34000830Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change.Stroke2021
33191851Computer-Assisted Measurement of Traumatic Brain Hemorrhage Volume Is More Predictive of Functional Outcome and Mortality than Standard ABC/2 Method: An Analysis of Computed Tomography Imaging Data from the Progesterone for Traumatic Brain Injury Experimental Clinical Treatment Phase-III Trial.J Neurotrauma2021
31484697Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis.J Neurointerv Surg2020
31795895National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.Stroke2020
32664792Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials.J Neurotrauma2020
32579278Hypoperfusion Distal to Anterior Circulation Intracranial Atherosclerosis is Associated with Recurrent Stroke.J Neuroimaging2020
30688974Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.JAMA Neurol2019
31495669Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities?J Stroke Cerebrovasc Dis2019
30730438The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial.Crit Care Med2019
30794101Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.J Neurotrauma2019
31112323Infarct Pattern, Perfusion Mismatch Thresholds, and Recurrent Cerebrovascular Events in Symptomatic Intracranial Stenosis.J Neuroimaging2019
30398302What Threshold Defines Penumbral Brain Tissue in Patients with Symptomatic Anterior Circulation Intracranial Stenosis: An Exploratory Analysis.J Neuroimaging2019
26596352The impact of covariate misclassification using generalized linear regression under covariate-adaptive randomization.Stat Methods Med Res2018
29998337Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.JAMA2018
29914457Determining the joint effect of obesity and diabetes on functional disability at 3-months and on all-cause mortality at 1-year following an ischemic stroke.BMC Endocr Disord2018
29986935Endovascular Treatment in the DEFUSE 3 Study.Stroke2018
30174819Determining the Joint Effect of Obesity and Diabetes on All-Cause Mortality and Cardiovascular-Related Mortality following an Ischemic Stroke.Stroke Res Treat2018
30037954Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes?J Neurointerv Surg2018
29364767Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.N Engl J Med2018
29570044Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design.Int J Stroke2018
29338483Reply to: Prehospital Intubation: Further Confounders in Trial Results.Prehosp Emerg Care2018
26973025Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury.J Neurotrauma2017
28489506Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III.Prehosp Emerg Care2017
28336740Towards personalised intra-arterial treatment of patients with acute ischaemic stroke: a study protocol for development and validation of a clinical decision aid.BMJ Open2017
28483774Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III.J Am Heart Assoc2017
28468840Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials.BMJ2017
28946832A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).Int J Stroke2017
28611830Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale.Interv Neurol2017
27765740Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.AJNR Am J Neuroradiol2017
26802090Effect of endovascular reperfusion in relation to site of arterial occlusion.Neurology2016
26658448Association Between CT Angiogram Collaterals and CT Perfusion in the Interventional Management of Stroke III Trial.Stroke2016
27895297Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data.Stroke2016
27781039Recanalization and Angiographic Reperfusion Are Both Associated with a Favorable Clinical Outcome in the IMS III Trial.Interv Neurol2016
  • 1 - 50 of 95

Recommended Authors

Natasha Ironside
University of Virginia Health System
Career Start Year 2017
Number of shared co-authors 1
Chung-Huan J Sun
University of California san francisco
Career Start Year 2010
Number of shared co-authors 7
Hooman Kamel
Weill Cornel School of Medicine
Career Start Year 2009
Number of shared co-authors 17
Matthew B Maas
Northwestern University Feinberg School of Medicine
Career Start Year 2009
Number of shared co-authors 4
Fabricio O Lima
Fortaleza General Hospital.
Career Start Year 2008
Number of shared co-authors 10
Ameer E Hassan
University of Texas Rio Grande Valley at Valley Baptist Medical Center
Career Start Year 2007
Number of shared co-authors 15
Holly E Hinson
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 3
Andrew M Southerland
The University of Virginia
Career Start Year 2005
Number of shared co-authors 10
Nils Henninger
University of Massachusetts
Career Start Year 2004
Number of shared co-authors 4
Christiana E Hall
UT Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 6
Bruce Ovbiagele
University of California san francisco
Career Start Year 2003
Number of shared co-authors 12
Georgios Tsivgoulis
"Attikon" University Hospital, National and Kapodistrian University of Athens
Career Start Year 2003
Number of shared co-authors 16
Matthew L Flaherty
University of Cincinnati College of Medicine
Career Start Year 2001
Number of shared co-authors 16
Brett M Kissela
University of Cincinnati
Career Start Year 2000
Number of shared co-authors 17
Steven R Mess??
Perelman School of Medicine University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 16
Ashutosh P Jadhav
Barrow Neurological Institute, St Joseph's Hospital and Medical Center
Career Start Year 1998
Number of shared co-authors 17
Bradford B Worrall
University of Virginia
Career Start Year 1997
Number of shared co-authors 19
Mitchell S V Elkind
Vagelos College of Physicians and Surgeons (D.Y., Columbia University
Career Start Year 1997
Number of shared co-authors 20
J Claude Hemphill
Mills Peninsula Medical Center
Career Start Year 1996
Number of shared co-authors 23
William T Kimberly
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1994
Number of shared co-authors 15
Jonathan Rosand
Center for Genomic Medicine, Massachusetts General Hospital
Career Start Year 1994
Number of shared co-authors 23
Jose I Suarez
Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 15
Andrei V Alexandrov
University of Arizona, Banner University Medical Center
Career Start Year 1993
Number of shared co-authors 15
Sean I Savitz
University of Texas Health Science Center at Houston
Career Start Year 1991
Number of shared co-authors 12
Nina T Gentile
Lewis Katz School of Medicine at Temple University
Career Start Year 1990
Number of shared co-authors 9
Christopher Lewandowski
Henry Ford Hospital
Career Start Year 1989
Number of shared co-authors 10
Lee H Schwamm
Massachusetts General Hospital
Career Start Year 1987
Number of shared co-authors 23
Eric E Smith
Cumming School of Medicine, University of Calgary
Career Start Year 1978
Number of shared co-authors 17
Thomas G Brott
Mayo Clinic
Career Start Year 1976
Number of shared co-authors 20
Lawrence R Wechsler
University of Pittsburgh School of Medicine
Career Start Year 1949
Number of shared co-authors 17

Collaborators

Joseph P Broderick
University of Cincinnati College of Medicine
Co-authored papers 37
Pooja Khatri
University of Cincinnati Medical Center
Co-authored papers 36
Robert Silbergleit
University of Michigan ann arbor
Co-authored papers 15
David S Liebeskind
University of California Los Angeles (D.S.L.).
Co-authored papers 14
Tudor G Jovin
Cooper Neurological Institute, Cooper University Hospital
Co-authored papers 12
Edward C Jauch
University of North Carolina Health Sciences at Mountain Area Health Education Center
Co-authored papers 11
William G Barsan
University of Michigan Medical School ann arbor
Co-authored papers 9
Lisa H Merck
Virginia Commonwealth University Health System
Co-authored papers 9
David W Wright
9Stanford University
Co-authored papers 8
Frederick K Korley
University of Michigan ann arbor
Co-authored papers 6
Jeffrey L Saver
Ronald Reagan university of california los angeles Medical Center
Co-authored papers 5
Dawn Kleindorfer
University of Michigan ann arbor
Co-authored papers 4
Kathleen T Brady
College of Medicine, Medical University of South Carolina
Co-authored papers 4
Karen L Furie
Alpert Medical School of Brown University
Co-authored papers 4
Geoffrey T Manley
University of California san francisco
Co-authored papers 4
Hester F Lingsma
Erasmus University Medical Center
Co-authored papers 3
Eva A Mistry
Vanderbilt University Medical Center
Co-authored papers 3
Steven R Levine
State University of New York Downstate Health Sciences University
Co-authored papers 3
Roger J Lewis
Harbor-university of california los angeles Medical Center
Co-authored papers 3
Christopher S Coffey
Co-authored papers 2
Natalia S Rost
Harvard Medical School
Co-authored papers 2
Robin Conwit
National Institute of Neurological Disorders and Stroke
Co-authored papers 2
Akshitkumar M Mistry
University of Louisville
Co-authored papers 2
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers 2
Chris Gennings
Co-authored papers 2
Vicki S Hertzberg
1Emory University
Co-authored papers 2
Lori Shutter
University of Pittsburgh School of Medicine
Co-authored papers 2
Jay Mocco
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Ramon Diaz-Arrastia
University of Pennsylvania
Co-authored papers 1
Larry T Davis
Vanderbilt University Medical Center
Co-authored papers 1
Release 1.2